Lipid Disorders
News
Diabetes prevalence increases, but so does diabetes control
Major finding: The prevalence of diagnosed diabetes in the United States rose significantly, from 6%-10% from 1988-2010.Data source: The findings...
Conference Coverage
ACC/AHA cardiovascular risk equations get a thumbs-up
Major finding: The controversial cardiovascular risk equations at the heart of the latest ACC/AHA risk-assessment guidelines turned in a moderate...
Conference Coverage
'Favorable signal' for secondary coronary prevention in STABILITY
Major finding: The combined rate of cardiovascular death, myocardial infarction, or stroke in patients randomized to darapladib was 9.7%, yielding...
Conference Coverage
VIDEO: PCSK9 inhibitors placed in perspective
News
One in four patients with hypertension nonadherent to therapy
Major finding: A urine test available to commercial labs showed that 25% of patients were totally (10.1%) or partially (14.9%) nonadherent to...
Conference Coverage
Bariatric surgery’s benefit persists in type 2 diabetes
Major finding: Significantly more patients treated with one of two types of bariatric surgery achieved the HbA1c target (37.5% and 24.5%) after 3...
Conference Coverage
Evolocumab betters ezetimibe for lowering LDL in statin-intolerant patients
Major finding: Statin-intolerant patients with hypercholesterolemia experienced mean 53%-56% reductions in LDL cholesterol in response to 12 weeks...
Conference Coverage
VIDEO: Novel drug misses mark for MI prevention, but shows promise
Conference Coverage
No improvements in left ventricular function with metformin after myocardial infarction
Major finding: Treatment with metformin after STEMI had no significant impact on LVEF or on the incidence of major cardiac events in nondiabetic...
Conference Coverage
'Revolutionary' LDL lowering shown in evolocumab phase III trials
Conference Coverage
Aleglitazar failed to reduce cardiovascular events in type 2 diabetes
Major finding: Aleglitazar failed to improve cardiovascular outcomes when compared with placebo and was linked with an increased risk of adverse...